This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:
A study led by Queen Mary University of London has found that the number of new cancer cases each year among transgender and gender-diverse people in England could more than double over the next decade.
The research, published in eClinicalMedicine, estimates that approximately 965 new cancer cases occur annually among transgender and gender-diverse people in England. This figure is projected to rise to around 1,739 cases in five years and 2,257 cases within 10 years.
The researchers indicate that the findings highlight the need for cancer services to prepare for the changing needs of this population, alongside improvements in cancer screening, health care professional training and the collection of patient data.
The study, believed to be the first to estimate the annual number of cancer cases among transgender and gender-diverse people in England, combined national cancer statistics, population data and existing research on the potential effects of gender-affirming health care.
Breast cancer was estimated to be the most common cancer in this population, accounting for approximately 19% of cases, followed by colorectal cancer at 12% and lung cancer at 11%.
Despite growing recognition of the health care needs of transgender and gender-diverse people, reliable national data on cancer incidence in this population remain limited.
Current cancer registration systems do not consistently distinguish between sex characteristics and gender identity, making it difficult to accurately understand cancer patterns and plan appropriate services.
Source link







